Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
Search
Close this search box.
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
Menu
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Generation of safe and therapeutically effective human induced hepatocyte-like cells

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Although the liver can regenerate itself, chronic or overwhelming damage can cause life-threatening liver failure. Currently, the only therapy for liver failure is liver transplantation. Because the supply of cadaveric…

Continue ReadingGeneration of safe and therapeutically effective human induced hepatocyte-like cells

Direct reprogramming towards vascular progenitors for the treatment of ischemia

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Angiogenesis or the generation of new blood vessels is a critical part of the normal healing process. Newly created vessels ensure the delivery of oxygen, nutrients, and specific repair signals…

Continue ReadingDirect reprogramming towards vascular progenitors for the treatment of ischemia

Identification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Autophagy is the cells mechanism for breaking down and recycling proteins. Danon disease is an inherited disorder of autophagy. Patients with this disease have major abnormalities in heart and skeletal…

Continue ReadingIdentification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease

Autologous iPSC Therapy for Urinary Incontinence

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Urinary incontinence (UI) is common and serious, with two-thirds of the burden borne by women. UI impacts both quality and length of life; women with UI suffer debilitating falls, experience…

Continue ReadingAutologous iPSC Therapy for Urinary Incontinence

Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells

  • Post author:
  • Post published:May 9, 2025
  • Post category:

This study addresses the cartilage defects resulting from injuries or from wear-and-tear that can eventually degenerate to osteoarthritis. This is a significant problem that impacts millions and costs in excess…

Continue ReadingTissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells

Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Multiple Sclerosis (MS) is a disease of the central nervous system (CNS) caused by inflammation and loss of cells that produce myelin, which normally insulates and protects nerve cells. MS…

Continue ReadingMultiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells

Human ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Transplantation of neuronal precursors into the central nervous system offers great promise for the treatment of neurological disorders including spinal cord injury (SCI). Among the most significant consequences of SCI…

Continue ReadingHuman ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury

Molecules to Correct Aberrant RNA Signature in Human Diseased Neurons

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Approximately 5,600 people in the U.S. are diagnosed with ALS each year. The incidence of ALS is two per 100,000 people, and it is estimated that as many as 30,000…

Continue ReadingMolecules to Correct Aberrant RNA Signature in Human Diseased Neurons

Interdisciplinary Stem Cell Training Program at UCSD II

  • Post author:
  • Post published:May 9, 2025
  • Post category:

This proposal describes a Type I stem cell training program including a School of Medicine, a Division of Biological Sciences, a School of Pharmacy and Pharmaceutical Sciences, and a School…

Continue ReadingInterdisciplinary Stem Cell Training Program at UCSD II

CHLA Stem Cell Training Grant

  • Post author:
  • Post published:May 9, 2025
  • Post category:

This Level II Training Grant will support seven PhD Post-Doctoral and three MD Clinical Fellows for training in stem cell biology, and the clinical and ethical implications of stem cell…

Continue ReadingCHLA Stem Cell Training Grant
  • Go to the previous page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 65
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us